Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.
Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.
On this Thanksgiving Day, we salute lung cancer patient Jason Karg and his wife Kristyl for reminding us of the important things in life. November is Lung Cancer Awareness Month. What are you grateful for?
Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.
Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.
Well, here we are, barring any last minute complications my wife should start the TAK-788 trial next week. She has already had her main blood work and...
One year ago I had a CT scan due to some symptoms. No tumor or other abnormality was found. Last week I had a CT for a kidney stone. The radiologist...
My husband has nocturia - bad. Since his pneumonectomy (T3 N1 M0) In October 2014 he has been up every two to three hours to pee. He has not had a...
Hi, my mom has EGFR mutation (Exon21). I would like to find an oncologist in Dana Farber or Sloan Kettering Institution for 2nd opinion. Can anybody...
Dx 11/2016. + for exon 19 deletion, Rx. with Tarceva for 18 months. Tolerated well. Now on Tagrisso, not sure how well I'm tolerating as it's only...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.